Oral Cancer News | Tag Archive | head and neck cancer

Big Data Unveils Exciting Head and Neck Cancer Targets

Wednesday, May 22, 2013

BioscienceTechnology.com Cynthia Fox Monday, May 20, 2013 Genome sequencing of head and neck cancers may quickly—and soon—spur new therapies. There are 20 tumor types being studied by the massive, $100 million Cancer Genome Atlas (TCGA) project. Head and neck squamous cell carcinoma (HNSCC) is the eighth to be unveiled. The first, glioblastoma, has been [...]

Drug Designed To Restore Cell Suicide In HPV-Related Head And Neck Cancer

Thursday, May 9, 2013

0 Comments

Article Date: 10 Apr 2013 – 1:00 PDT Source: Medical News Today Researchers have discovered a new mechanism by which the human papilloma virus (HPV) causes head and neck cancer, and they have designed a drug to block that mechanism. Though further research is needed, the new agent might offer a safer treatment for [...]

Nearly 6 Percent Of Lung Cancer Tissue Samples From Non-Smokers Show Signs That HPV May Have Triggered The Tumors

Thursday, May 9, 2013

0 Comments

Article Date: 12 Apr 2013 – 1:00 PDT Source: Medical News Today A common virus known to cause cervical and head and neck cancers may also trigger some cases of lung cancer, according to new research presented by Fox Chase Cancer Center at the AACR Annual Meeting 2013. Examining tissue samples from lung cancer [...]

Researchers Design Drug to Restore Cell Suicide in HPV-Related Head and Neck Cancer

Tuesday, April 9, 2013

0 Comments

Source: sciencedaily.com Date: April 8, 2013 Researchers have discovered a new mechanism by which the human papilloma virus (HPV) causes head and neck cancer, and they have designed a drug to block that mechanism. Though further research is needed, the new agent might offer a safer treatment for these tumors when combined with a [...]

Targeted Drugs No Help in Head and Neck Cancer

Thursday, March 7, 2013

0 Comments

Source: medpagetoday.com Author: Charles Bankhead, Staff Writer, MedPage Today Date: March 05, 2013 The addition of targeted agents to standard chemotherapy failed to improve efficacy in two different trials of advanced head and neck cancer. In one trial, patients given gefitinib (Iressa) in addition to docetaxel lived about a month longer than those [...]

HPV vaccine issue returns to legislature

Wednesday, January 16, 2013

0 Comments

Source: abcnews4.com Date: January 14, 2013 by Stacy Jacobson CHARLESTON, S.C. (WCIV) — A local state representative will introduce a bill that would give middle school students better accessibility to information about the Human Papilloma Virus vaccine and to the vaccine itself. Gov. Nikki Haley vetoed the bill last year. But lawmakers wanted to try again. HPV [...]

The effect of treating institution on outcomes in head and neck cancer

Friday, December 7, 2012

0 Comments

Source: American Academy of Otolaryngology – Head and Neck Surgery Alexandria, VA — Patients with head and neck cancer receiving radiation treatment at an academic center have a higher survival rate than those receiving treatment at a community center, according to a study in the December 2012 issue of Otolaryngology–Head and Neck Surgery. “Despite similar rates [...]

First gene therapy study in human salivary gland shows promise

Tuesday, November 6, 2012

0 Comments

Source: National Institutes of Health (NIH) Date: Monday, November 5, 2012 Gene therapy can be performed safely in the human salivary gland, according to scientists at the National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health. This finding comes from the first-ever safety, or Phase I, clinical study of gene [...]

Germany’s Merck halts supply of cancer drug to Greek hospitals

Monday, November 5, 2012

0 Comments

Source: Reuters.com Date: November 3, 2012 German pharmaceuticals firm Merck KGaA is no longer delivering cancer drug Erbitux to Greek hospitals, a spokesman said on Saturday, the latest sign of how an economic and budget crisis is hurting frontline public services. Drugmakers raised concerns with EU leaders earlier this year over supplies to the euro zone’s crisis-hit [...]

Studies question value of certain HNC biomarkers

Friday, September 28, 2012

0 Comments

Source: Dr.Biscuspid.com September 19, 2012 — Human papillomavirus (HPV) DNA positivity alone, particularly when assessed using polymerase chain reaction methods, is a poor biomarker for HPV-driven head and neck cancers (HNCs), according to two studies published in Cancer Research (September 18, 2012). These studies identified alternative potential markers, including viral load, viral gene expression, and [...]

Tag Archive | "head and neck cancer"